✦ LIBER ✦

A randomized, multi-central, controlled study of patients with hepatitis B e antigen-positive chronic hepatitis B treated by adefovir dipivoxil or adefovir dipivoxil plus bicyclol

✍ Scribed by Wen Xie; Guangfeng Shi; Hongfei Zhang; Guiming Zhao; Zujiang Yu; Zhenwei Lang; Hong Zhao; Jie Yan; Jun Cheng

Book ID: 113094647
Publisher: Springer-Verlag
Year: 2011
Tongue: English
Weight: 658 KB
Volume: 6
Category: Article
ISSN: 1936-0533
DOI: 10.1007/s12072-011-9294-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

709 A RANDOMIZED, CONTROLLED, OPEN-LABEL

709 A RANDOMIZED, CONTROLLED, OPEN-LABELED, MULTI-CENTER STUDY OF HBEAG-POSITIVE CHRONIC VIRAL HEPATITIS B PATIENTS TREATED BY ADEFOVIR DIPIVOXIL OR COMBINED WITH BICYCLOL

✍ J. Cheng; G.-F. Shi; H.-F. Zhang; G.-M. Zhao; Z.-J. Yu; Z.-W. Lang 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Renal safety of adefovir dipivoxil in pa

Renal safety of adefovir dipivoxil in patients with chronic hepatitis B: Two double-blind, randomized, placebo-controlled studies

✍ Izzedine, Hassane; Hulot, Jean Sebastien; Launay-Vacher, Vincent; Marcellini, Pa 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 68 KB

Early hepatitis B virus DNA reduction in

Early hepatitis B virus DNA reduction in hepatitis B e antigen–positive patients with chronic hepatitis B: A randomized international study of entecavir versus adefovir

✍ Nancy Leung; Cheng-Yuan Peng; Hie-Won Hann; Jose Sollano; Judy Lao-Tan; Chao-Wei 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 382 KB 👁 2 views

This study was undertaken to compare the early antiviral activity and viral kinetic profiles of entecavir (ETV) versus adefovir (ADV) in hepatitis B e antigen positive nucleoside-naïve adults with chronic hepatitis B (CHB). Sixty-nine nucleoside-naïve CHB patients with baseline HBV DNA of 10(8) copi

501 Adefovir dipivoxil alone or in combi

501 Adefovir dipivoxil alone or in combination with lamivudine in HBeAg negative patients with lamivudine resistant chronic hepatitis B: A prospective, randomized study

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 129 KB

Hepatitis B e antigen predicts delayed r

Hepatitis B e antigen predicts delayed reduction of HBV DNA without viral breakthrough with adefovir dipivoxil and lamivudine: A 5-year study of patients with hepatitis B with lamivudine resistance

✍ Fusao Ikeda; Nobuyuki Baba; Koichi Takaguchi; Junichi Kubota; Kenji Miyoshi; Shi 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 288 KB

GS-98-438 a double-blind, randomized, pl

GS-98-438 a double-blind, randomized, placebo-controlled study of adefovir dipivoxil (ADV) for presumed precore mutant chronic hepatitis B: 48 week results

✍ S. Hadziyannis; N. Tassopolous; E. Heathcote; T.T. Chang; G. Kitis; T. Rizzetto; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 139 KB